ATEZOLIZUMAB AND HYALURONIDASE-TQJS

ATEZOLIZUMAB AND HYALURONIDASE-TQJS was reported 24 times

ATEZOLIZUMAB AND HYALURONIDASE-TQJS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HILAR LYMPHADENOPATHY 1 0.0011
1 PRODUCT AFTER TASTE 1 0.0010
2 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
3 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
4 HEPATOCELLULAR CARCINOMA 1 0.0001
5 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
6 HEPATITIS 1 0.0000
7 PNEUMONITIS 1 0.0000
8 RESPIRATORY DISTRESS 1 0.0000
9 BLISTER 2 0.0000
10 HYPOXIA 1 0.0000
11 PRODUCT STORAGE ERROR 2 0.0000
12 NO ADVERSE EVENT 4 0.0000
13 TREATMENT NONCOMPLIANCE 1 0.0000
14 STOMATITIS 1 0.0000
15 DEEP VEIN THROMBOSIS 1 0.0000
16 INFUSION RELATED REACTION 1 0.0000
17 BURNING SENSATION 1 0.0000
18 INJECTION SITE SWELLING 1 0.0000
19 INJECTION SITE PAIN 4 0.0000
20 FLUSHING 1 0.0000
21 THROMBOCYTOPENIA 1 0.0000
22 HYPOAESTHESIA 1 0.0000
23 ABDOMINAL DISCOMFORT 1 0.0000
24 GAIT DISTURBANCE 1 0.0000
25 MALAISE 2 0.0000
26 PAIN IN EXTREMITY 1 0.0000
27 PAIN 2 0.0000
28 PRURITUS 1 0.0000
29 DIZZINESS 1 0.0000
30 DYSPNOEA 1 0.0000
31 FATIGUE 1 0.0000
32 DEATH 1 0.0000
33 OFF LABEL USE 1 0.0000